Cargando…

Pre-operative screening for obstructive sleep apnoea

Sleep disordered breathing, especially obstructive sleep apnoea (OSA), has a high and increasing prevalence. Depending on the apnoea and hypopnoea scoring criteria used, and depending on the sex and age of the subjects investigated, prevalence varies between 3% and 49% of the general population. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Verbraecken, Johan, Hedner, Jan, Penzel, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489116/
https://www.ncbi.nlm.nih.gov/pubmed/28049125
http://dx.doi.org/10.1183/16000617.0012-2016
_version_ 1784792807470268416
author Verbraecken, Johan
Hedner, Jan
Penzel, Thomas
author_facet Verbraecken, Johan
Hedner, Jan
Penzel, Thomas
author_sort Verbraecken, Johan
collection PubMed
description Sleep disordered breathing, especially obstructive sleep apnoea (OSA), has a high and increasing prevalence. Depending on the apnoea and hypopnoea scoring criteria used, and depending on the sex and age of the subjects investigated, prevalence varies between 3% and 49% of the general population. These varying prevalences need to be reflected when considering screening for OSA. OSA is a cardiovascular risk factor and patients are at risk when undergoing medical interventions such as surgery. Screening for OSA before anaesthesia and surgical interventions is increasingly considered. Therefore, methods for screening and the rationale for screening for OSA are reviewed in this study.
format Online
Article
Text
id pubmed-9489116
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-94891162022-11-14 Pre-operative screening for obstructive sleep apnoea Verbraecken, Johan Hedner, Jan Penzel, Thomas Eur Respir Rev Reviews Sleep disordered breathing, especially obstructive sleep apnoea (OSA), has a high and increasing prevalence. Depending on the apnoea and hypopnoea scoring criteria used, and depending on the sex and age of the subjects investigated, prevalence varies between 3% and 49% of the general population. These varying prevalences need to be reflected when considering screening for OSA. OSA is a cardiovascular risk factor and patients are at risk when undergoing medical interventions such as surgery. Screening for OSA before anaesthesia and surgical interventions is increasingly considered. Therefore, methods for screening and the rationale for screening for OSA are reviewed in this study. European Respiratory Society 2017-01-03 /pmc/articles/PMC9489116/ /pubmed/28049125 http://dx.doi.org/10.1183/16000617.0012-2016 Text en Copyright ©ERS 2017. https://creativecommons.org/licenses/by-nc/4.0/ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Reviews
Verbraecken, Johan
Hedner, Jan
Penzel, Thomas
Pre-operative screening for obstructive sleep apnoea
title Pre-operative screening for obstructive sleep apnoea
title_full Pre-operative screening for obstructive sleep apnoea
title_fullStr Pre-operative screening for obstructive sleep apnoea
title_full_unstemmed Pre-operative screening for obstructive sleep apnoea
title_short Pre-operative screening for obstructive sleep apnoea
title_sort pre-operative screening for obstructive sleep apnoea
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489116/
https://www.ncbi.nlm.nih.gov/pubmed/28049125
http://dx.doi.org/10.1183/16000617.0012-2016
work_keys_str_mv AT verbraeckenjohan preoperativescreeningforobstructivesleepapnoea
AT hednerjan preoperativescreeningforobstructivesleepapnoea
AT penzelthomas preoperativescreeningforobstructivesleepapnoea